D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents

BACKGROUND: D‐Cycloserine has potential to enhance exposure therapy outcomes. The current study presents a preliminary randomized, placebo‐controlled double‐blind pilot trial of DCS‐augmented one‐session treatment (OST) for youth (7–14 years) with specific phobia. A secondary aim of this pilot study...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrell, Lara J., Waters, Allison M., Oar, Ella L., Tiralongo, Evelin, Garbharran, Vinay, Alston‐Knox, Clair, McConnell, Harry, Collings, Nigel, Zimmer‐Gembeck, Melanie, Donovan, Caroline L., Testa, Chris, Storch, Eric A., Ollendick, Thomas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991588/
https://www.ncbi.nlm.nih.gov/pubmed/30106248
http://dx.doi.org/10.1002/brb3.984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991588/
https://www.ncbi.nlm.nih.gov/pubmed/30106248
http://dx.doi.org/10.1002/brb3.984

Ejemplares similares